Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

62.34
Delayed Data
As of 4:04pm ET
 +0.88 / +1.43%
Today’s Change
45.45
Today|||52-Week Range
71.60
+5.23%
Year-to-Date

Today’s Trading

Previous close61.46
Today’s open61.41
Day’s range61.09 - 62.40
Volume8,646,174
Average volume (3 months)8,163,601
Market cap$99.4B
Dividend yield3.66%
Data as of 4:04pm ET, 05/05/2016

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+12.45%
Earnings growth (next 5 years)+14.40%
Revenue growth (last year)+14.52%
P/E ratio19.8
Price/Sales4.24
Price/Book25.07

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.07+0.17%
SNYSanofi+0.32+0.83%
NVONovo Nordisk-0.25-0.46%
AGNAllergan-4.28-1.99%
Data as of 4:02pm ET, 05/05/2016

Financials

Next reporting dateJuly 22, 2016
EPS forecast (this quarter)$1.22
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers

Search for Jobs